Search research articles
Contact Us
Filters
Showing results (171-180 of 10,653) with videos related to
Page
of 1,066
Sort By:
Current Pharmaceutical Design
|
November 16, 2006
Views on amyloid hypothesis and secretase inhibitors for treating Alzheimer's disease: progress and problems
Jeffrey-Tri Nguyen, Abdellah Yamani, Yoshiaki Kiso
Current Pharmaceutical Design
|
February 22, 2007
Inflammatory caspases: targets for novel therapies
Sigrid Cornelis, Kristof Kersse, Nele Festjens, et al.
Current Pharmaceutical Design
|
February 23, 2007
Activity based probes for proteases: applications to biomarker discovery, molecular imaging and drug screening
Marko Fonović, Matthew Bogyo
Current Pharmaceutical Design
|
March 10, 2007
Purine metabolism in Mycobacterium tuberculosis as a target for drug development
William B Parker, Mary C Long
Current Pharmaceutical Design
|
March 10, 2007
Invasion and egress by the obligate intracellular parasite Toxoplasma gondii: potential targets for the development of new antiparasitic drugs
M D Lavine, G Arrizabalaga
Current Pharmaceutical Design
|
March 10, 2007
Anti-apoptotic actions of insulin-like growth factors: lessons from development and implications in neoplastic cell transformation
Isabel Varela-Nieto, Markus Hartl, Itziar Gorospe, et al.
Current Pharmaceutical Design
|
March 14, 2007
Current concepts for the combined treatment modality of ionizing radiation with anticancer agents
Christoph Oehler, Daniel J Dickinson, Angela Broggini-Tenzer, et al.
Current Pharmaceutical Design
|
October 6, 2006
Treatment of allergic asthma by targeting transcription factors using nucleic-acid based technologies
Serdar Sel, Wolfgang Henke, Alexander Dietrich, et al.
Current Pharmaceutical Design
|
November 15, 2006
Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities
Haruaki Tomioka
Current Pharmaceutical Design
|
November 15, 2006
Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling
H Takada, A Uehara
Page
of 1,066
Search research articles
Search
Showing results (171-180 of 10,653) with videos related to
Sort By:
Page
of 1,066
Current Pharmaceutical Design
|
November 16, 2006
Views on amyloid hypothesis and secretase inhibitors for treating Alzheimer's disease: progress and problems
Jeffrey-Tri Nguyen, Abdellah Yamani, Yoshiaki Kiso
Current Pharmaceutical Design
|
February 22, 2007
Inflammatory caspases: targets for novel therapies
Sigrid Cornelis, Kristof Kersse, Nele Festjens, et al.
Current Pharmaceutical Design
|
February 23, 2007
Activity based probes for proteases: applications to biomarker discovery, molecular imaging and drug screening
Marko Fonović, Matthew Bogyo
Current Pharmaceutical Design
|
March 10, 2007
Purine metabolism in Mycobacterium tuberculosis as a target for drug development
William B Parker, Mary C Long
Current Pharmaceutical Design
|
March 10, 2007
Invasion and egress by the obligate intracellular parasite Toxoplasma gondii: potential targets for the development of new antiparasitic drugs
M D Lavine, G Arrizabalaga
Current Pharmaceutical Design
|
March 10, 2007
Anti-apoptotic actions of insulin-like growth factors: lessons from development and implications in neoplastic cell transformation
Isabel Varela-Nieto, Markus Hartl, Itziar Gorospe, et al.
Current Pharmaceutical Design
|
March 14, 2007
Current concepts for the combined treatment modality of ionizing radiation with anticancer agents
Christoph Oehler, Daniel J Dickinson, Angela Broggini-Tenzer, et al.
Current Pharmaceutical Design
|
October 6, 2006
Treatment of allergic asthma by targeting transcription factors using nucleic-acid based technologies
Serdar Sel, Wolfgang Henke, Alexander Dietrich, et al.
Current Pharmaceutical Design
|
November 15, 2006
Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities
Haruaki Tomioka
Current Pharmaceutical Design
|
November 15, 2006
Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling
H Takada, A Uehara
Page
of 1,066